“…Initial studies evaluating this model in chronic SZ provided strong support, indicating that: (a) DPBs are elevated in SZ compared to controls, (b) DPBs are associated with negative symptoms, poor functioning and cognitive impairment, and (c) DPBs mediate the associations between neurocognition and negative symptoms, and neurocognition and functioning Rector et al, 2005). Subsequent studies have consistently replicated initial findings of increased DPBs in SZ compared to controls (Granholm et al, 2016;Horan et al, 2010;Kiwanuka et al, 2014;Strauss et al, 2015;Takeda et al, 2019;Ventura et al, 2014;Zimmerman et al, 1986). However, correlations between DPB and negative symptoms, functional outcome and neurocognition are less consistent (Couture et al, 2011;Reddy et al, 2018;Granholm et al, 2016;Green et al, 2012;Horan et al, 2010;Kiwanuka et al, 2014;Le et al, 2018;Pillny & Lincoln, 2016;Quinlan et al, 2015;Takeda et al, 2019;Ventura et al, 2014), with a meta-analysis by Campellone et al (2016)indicating a smalleffect size for the association between DPBs with negative symptoms (r = .24) and functional outcome (r = −.27).…”